JG
GTHX

Jefferies Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Jefferies Group’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,567
Closed -$423K – 3102
2019
Q3 		$423K Buy
+18,567
New +$585K ﹤0.01% 1975

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Jefferies Group's GTHX Position: Q4 2019 in Review

Jefferies Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2019, closing a stake of 18,567 shares — an estimated $423K sold.

Jefferies Group first reported a position in GTHX in Q3 2019 and held it in 1 quarter. The position peaked at $423K in Q3 2019. 98 funds tracked by Wall St. Rank hold GTHX as of Q4 2019.

  • Jefferies Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 18,567 G1 Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $423K.
  • Jefferies Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Jefferies Group's G1 Therapeutics, Inc. Common Stock position peaked at $423K in Q3 2019.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.